• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

碳青霉烯类耐药肺炎克雷伯菌临床分离株中磷霉素耐药机制的研究。

Mechanisms of fosfomycin resistance in clinical isolates of carbapenem-resistant Klebsiella pneumoniae.

机构信息

Department of Clinical Laboratory, The Second Affiliated Hospital and Yuying Children's Hospital of Wenzhou Medical University, 109 Xueyuan W Road, Wenzhou 325000, Zhejiang Province, China; Department of Clinical Laboratory, The First Affiliated Hospital of Nanchang University, Nanchang, Jiangxi Province, China.

Department of Clinical Laboratory, The Second Affiliated Hospital and Yuying Children's Hospital of Wenzhou Medical University, 109 Xueyuan W Road, Wenzhou 325000, Zhejiang Province, China.

出版信息

J Glob Antimicrob Resist. 2020 Sep;22:238-243. doi: 10.1016/j.jgar.2019.12.019. Epub 2020 Feb 13.

DOI:10.1016/j.jgar.2019.12.019
PMID:32061879
Abstract

OBJECTIVES

Older antimicrobials such as fosfomycin are being considered as alternative agents in the treatment of drug-resistant organisms. However, there are limited data on the usefulness of fosfomycin against carbapenem-resistant Klebsiella pneumoniae (CRKP). This study aimed to investigate the prevalence of fosfomycin resistance and associated mechanisms in CRKP.

METHODS

A total of 99 clinical CRKP isolates were collected in the Second Affiliated Hospital of Wenzhou Medical University (Wenzhou, China) between January 2017 and June 2018. Fosfomycin susceptibility testing was performed by the agar dilution method. Carbapenemase and fosfomycin resistance genes were detected by PCR. Analysis of the murA, glpT, uhpT, uhpA, ptsI and cyaA genes was performed by PCR and sequencing of four fosfomycin-resistant fosA3-negative CRKP strains. Conjugation experiments were employed to determine the mobility of the fosA3 gene.

RESULTS

Of the 99 CRKP isolates, fosfomycin-non-susceptibility was detected in 48 (48.5%) isolates, among which the fosA3 gene was detected in 44. Among the four fosfomycin-resistant fosA3-negative CRKP isolates, one isolate possessed a single nucleotide insertion and deletion mutations as well as 219 nucleotide substitution mutations in murA, two isolates possessed deletion or mutation of large DNA fragments in glpT, and one isolate possessed a fragment insertion sequence in glpT. Transfection into Escherichia coli J53 via plasmid conjugation was successful for 19 (43.2%) of the 44 fosA3-positive CRKP isolates.

CONCLUSION

The fosA3 gene is the primary mechanism of fosfomycin resistance in CRKP and can be transmitted widely by plasmid in hospitals. Mutations in murA and glpT were found in fosfomycin-resistant fosA3-negative CRKP.

摘要

目的

诸如磷霉素等较老的抗生素正被视为治疗耐药菌的替代药物。然而,关于磷霉素对耐碳青霉烯类肺炎克雷伯菌(CRKP)的有效性的数据有限。本研究旨在调查 CRKP 中磷霉素耐药的流行情况及其相关机制。

方法

本研究共收集了 2017 年 1 月至 2018 年 6 月期间在温州医科大学附属第二医院(温州,中国)的 99 株临床 CRKP 分离株。采用琼脂稀释法进行磷霉素药敏试验。通过 PCR 检测碳青霉烯酶和磷霉素耐药基因。通过 PCR 和测序分析 4 株磷霉素耐药但 fosA3 阴性的 CRKP 株的 murA、glpT、uhpT、uhpA、ptsI 和 cyaA 基因。采用接合实验来确定 fosA3 基因的移动性。

结果

在 99 株 CRKP 分离株中,48 株(48.5%)对磷霉素表现为非敏感性,其中 44 株检测到 fosA3 基因。在 4 株磷霉素耐药但 fosA3 阴性的 CRKP 分离株中,1 株 murA 基因发生单个核苷酸插入和缺失突变以及 219 个核苷酸取代突变,2 株 glpT 基因发生大片段缺失或突变,1 株 glpT 基因发生插入序列片段。通过质粒接合将 fosA3 阳性的 44 株 CRKP 分离株中的 19 株(43.2%)转染到大肠杆菌 J53 中是成功的。

结论

fosA3 基因是 CRKP 中磷霉素耐药的主要机制,并且可以通过质粒在医院中广泛传播。在磷霉素耐药但 fosA3 阴性的 CRKP 中发现 murA 和 glpT 突变。

相似文献

1
Mechanisms of fosfomycin resistance in clinical isolates of carbapenem-resistant Klebsiella pneumoniae.碳青霉烯类耐药肺炎克雷伯菌临床分离株中磷霉素耐药机制的研究。
J Glob Antimicrob Resist. 2020 Sep;22:238-243. doi: 10.1016/j.jgar.2019.12.019. Epub 2020 Feb 13.
2
Molecular Epidemiology of Plasmid-Mediated Fosfomycin Resistance Gene Determinants in Klebsiella pneumoniae Carbapenemase-Producing Klebsiella pneumoniae Isolates in China.中国产肺炎克雷伯菌碳青霉烯酶肺炎克雷伯菌分离株中质粒介导磷霉素耐药基因决定子的分子流行病学
Microb Drug Resist. 2019 Mar;25(2):251-257. doi: 10.1089/mdr.2018.0137. Epub 2018 Aug 16.
3
The plasmid-mediated fosfomycin resistance determinants and synergy of fosfomycin and meropenem in carbapenem-resistant Klebsiella pneumoniae isolates in Taiwan.台湾碳青霉烯类耐药肺炎克雷伯菌分离株中介导磷霉素耐药的质粒决定因子和磷霉素与美罗培南的协同作用。
J Microbiol Immunol Infect. 2017 Oct;50(5):653-661. doi: 10.1016/j.jmii.2017.03.003. Epub 2017 Jun 28.
4
Characterization of fosfomycin resistance and molecular epidemiology among carbapenem-resistant Klebsiella pneumoniae strains from two tertiary hospitals in China.中国两家三级医院耐碳青霉烯肺炎克雷伯菌的磷霉素耐药性特征及分子流行病学研究。
BMC Microbiol. 2021 Apr 11;21(1):109. doi: 10.1186/s12866-021-02165-7.
5
Antimicrobial susceptibility and mechanisms of fosfomycin resistance in extended-spectrum β-lactamase-producing Escherichia coli strains from urinary tract infections in Wenzhou, China.中国温州尿路感染中产超广谱β-内酰胺酶大肠埃希菌的药敏情况及耐药机制研究
Int J Antimicrob Agents. 2017 Jul;50(1):29-34. doi: 10.1016/j.ijantimicag.2017.02.010. Epub 2017 Apr 26.
6
Dissemination of a clone carrying a fosA3-harbouring plasmid mediates high fosfomycin resistance rate of KPC-producing Klebsiella pneumoniae in China.携带 fosA3 质粒的克隆传播导致中国产 KPC 肺炎克雷伯菌对磷霉素高度耐药。
Int J Antimicrob Agents. 2015 Jan;45(1):66-70. doi: 10.1016/j.ijantimicag.2014.08.010. Epub 2014 Oct 2.
7
Transporter Genes and fosA Associated With Fosfomycin Resistance in Carbapenem-Resistant .与耐碳青霉烯类药物中磷霉素耐药相关的转运体基因和fosA
Front Microbiol. 2022 Jan 31;13:816806. doi: 10.3389/fmicb.2022.816806. eCollection 2022.
8
Prevalence and mechanisms of fosfomycin resistance among KPC-producing Klebsiella pneumoniae clinical isolates in China.中国产 KPC 肺炎克雷伯菌临床分离株中磷霉素耐药的流行情况及机制。
Int J Antimicrob Agents. 2021 Jan;57(1):106226. doi: 10.1016/j.ijantimicag.2020.106226. Epub 2020 Nov 16.
9
fosA3 overexpression with transporter mutations mediates high-level of fosfomycin resistance and silence of fosA3 in fosfomycin-susceptible Klebsiella pneumoniae producing carbapenemase clinical isolates.携带转运基因突变的 fosA3 过度表达导致高产水平的磷霉素耐药性,并使产碳青霉烯酶的敏感型肺炎克雷伯菌临床分离株中的 fosA3 沉默。
PLoS One. 2020 Aug 28;15(8):e0237474. doi: 10.1371/journal.pone.0237474. eCollection 2020.
10
Prevalence of acquired fosfomycin resistance among extended-spectrum β-lactamase-producing Escherichia coli and Klebsiella pneumoniae clinical isolates in Korea and IS26-composite transposon surrounding fosA3.韩国产超广谱β-内酰胺酶的大肠埃希菌和肺炎克雷伯菌临床分离株中获得性磷霉素耐药的流行情况和 IS26 复合转座子周围的 fosA3。
J Antimicrob Chemother. 2012 Dec;67(12):2843-7. doi: 10.1093/jac/dks319. Epub 2012 Aug 14.

引用本文的文献

1
Heteroresistance associated with the production of fosfomycin-resistant inner colonies during disk diffusion testing among a geographically diverse collection of clinical isolates.在来自不同地理区域的临床分离株集合中,纸片扩散试验期间与磷霉素耐药内部菌落产生相关的异质性耐药。
JAC Antimicrob Resist. 2025 Feb 20;7(1):dlaf013. doi: 10.1093/jacamr/dlaf013. eCollection 2025 Feb.
2
In Vitro Synergistic Effect of Colistin with Fosfomycin Against Carbapenem-Resistant Klebsiella pneumoniae.黏菌素与磷霉素对耐碳青霉烯类肺炎克雷伯菌的体外协同作用
Cureus. 2024 Aug 6;16(8):e66295. doi: 10.7759/cureus.66295. eCollection 2024 Aug.
3
Bacteriological and molecular study of fosfomycin resistance in uropathogenic Escherichia coli.
尿路致病性大肠埃希菌中磷霉素耐药性的细菌学和分子研究。
Braz J Microbiol. 2024 Jun;55(2):1091-1097. doi: 10.1007/s42770-024-01272-7. Epub 2024 Feb 17.
4
Study of Antimicrobial Resistance (AMR) in spp. in India.印度某菌属的抗菌药物耐药性(AMR)研究。 (注:原文中“ spp.”表述有误,可能是“species”等词的错误形式,根据语境推测这里应该是指某个具体菌属,但仅从给定原文难以准确明确具体所指菌属,故按照大致意思翻译为“某菌属” )
Recent Adv Antiinfect Drug Discov. 2024;19(3):182-196. doi: 10.2174/0127724344268156231129095108.
5
In-patient evolution of a high-persister strain with reduced in vivo antibiotic susceptibility.高耐株的住院患者病情演变,其体内抗生素敏感性降低。
Proc Natl Acad Sci U S A. 2024 Jan 16;121(3):e2314514121. doi: 10.1073/pnas.2314514121. Epub 2024 Jan 8.
6
Characteristics of antibiotic resistance mechanisms and genes of ..的抗生素耐药机制及基因特征
Open Med (Wars). 2023 May 12;18(1):20230707. doi: 10.1515/med-2023-0707. eCollection 2023.
7
Molecular typing methods & resistance mechanisms of MDR .多重耐药菌的分子分型方法及耐药机制
AIMS Microbiol. 2023 Feb 27;9(1):112-130. doi: 10.3934/microbiol.2023008. eCollection 2023.
8
In Vitro and In Vivo Synergism of Fosfomycin in Combination with Meropenem or Polymyxin B against KPC-2-Producing Clinical Isolates.磷霉素与美罗培南或多粘菌素B联合应用对产KPC-2临床分离株的体外和体内协同作用
Antibiotics (Basel). 2023 Jan 23;12(2):237. doi: 10.3390/antibiotics12020237.
9
In Vitro Activity of Fosfomycin on Multidrug-Resistant Strains of Klebsiella pneumoniae and Klebsiella oxytoca Causing Urinary Tract Infection.磷霉素对引起尿路感染的肺炎克雷伯菌和产酸克雷伯菌多重耐药菌株的体外活性
Curr Microbiol. 2023 Feb 24;80(4):115. doi: 10.1007/s00284-023-03208-0.
10
Effect of Colistin, Fosfomycin and Meropenem/Vaborbactam on Carbapenem-Resistant in Egypt: A Cross-Sectional Study.黏菌素、磷霉素和美罗培南/瓦博巴坦对埃及耐碳青霉烯类细菌的影响:一项横断面研究
Infect Drug Resist. 2022 Oct 27;15:6203-6214. doi: 10.2147/IDR.S385411. eCollection 2022.